Prevalence of Poor Glycemic Control and Its Related Factors Among Iranian Diabetic Patients Who Participated in KERCARDS

نویسندگان

1 پردیس فارابی دانشگاه تهران

2 دانشگاه آزاد اسلامی

3 دانشگاه آزاد اسلامی

4 دانشگاه آزاد اسلامی

5 دانشگاه آزاد اسلامی

6 دانشگاه فنی و حرفه‌ای

7 دانشگاه آزاد اسلامی

doi
10.48307/iahsj.2025.440930.1138
چکیده

Objectives : Diabetes is a leading cause of mortality with a rising trend worldwide, and uncontrolled hyperglycemia causes several chronic complications. This study was conducted to investigate the prevalence of poor glycemic control and its related factors among diabetics in southeast Iran. Methods : This was a cross-sectional study, and the study population was all participants in the second round of the KERCADR project. All of the patients were enrolled in the study using the census method. All data were recorded in a research-made checklist that consisted of 4 parts of demographic information, disease characteristics and complications, and results of clinical examinations. Descriptive statistics and logistic regression models were performed. Results : In total, 445 patients with type II diabetes participated. Metformin was the most frequent medicine (76.8%). Age between 55-64 years (aOR: 1.82, P-value: 0.02), duration of diabetes above 10 years (aOR: 1.78, P-value:0.02) and using insulin (aOR: 2.32, P-value: 0.04), glibenclamide (aOR:2.48, P-value:0.04) and using both glibenclamide and metformin (aOR: 2.45, P-value: 0.002), in combination with only metformin determined as predictor factors of poor glycemic control. Conclusion : The findings emphasized the considerably high prevalence of poor glycemic control. Healthcare providers should develop tailored treatment plans. Patients with a history of long-term diabetes or who use certain medications might benefit from more frequent monitoring and adjusted dosages. The study highlights the need for tailored management strategies based on patient-specific factors. This leads to more cooperation from patients in the treatment process and timely diagnosis of disease-related complications.